289.92 USD
▲+0.42+0.15%
盘后 290.21 +0.10%
2026-11-19
市值
$40.20B
市盈率
—
EPS
-1.16
股息率
—
52 周区间
181.00 – 437.41
成交量
2.74M
Beta
1.52
目标价
412.36
52W 低 181.0052W 高 437.41
价格走势

公司简介

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizo...

关联新闻